Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

被引:0
|
作者
Vallerie V. McLaughlin
Pavel Jansa
Jens E. Nielsen-Kudsk
Michael Halank
Gérald Simonneau
Ekkehard Grünig
Silvia Ulrich
Stephan Rosenkranz
Miguel A. Gómez Sánchez
Tomás Pulido
Joanna Pepke-Zaba
Joan Albert Barberá
Marius M. Hoeper
Jean-Luc Vachiéry
Irene Lang
Francine Carvalho
Christian Meier
Katharina Mueller
Sylvia Nikkho
Andrea M. D’Armini
机构
[1] University of Michigan Health System,Department of Cardiological Medicine
[2] Cardiology and Angiology Department,Thoraxclinic
[3] General University Hospital,Clinic of Pulmonology
[4] Aarhus University,Department III of Internal Medicine
[5] University Hospital Dresden,Unidad de I. Cardiaca e Hipertensión Pulmonar
[6] Hôpital Bicêtre,Department of Pulmonary Medicine, Hospital Clínic
[7] Université Paris-Sud,IDIBAPS
[8] Laboratoire d’Excellence en Recherche sur le Médicament et Innovation Thérapeutique,Département de Cardiologie, Hôpital Erasme
[9] and INSERM Unité 999,Allgemeines Krankenhaus der Stadt Wien
[10] University Hospital Heidelberg,Division of Cardiothoracic Surgery, Foundation “IRCCS Policlinico San Matteo”
[11] University Hospital Zurich,undefined
[12] Cologne University Heart Center,undefined
[13] Hospital Universitario 12 de Octubre,undefined
[14] Instituto Nacional de Cardiología,undefined
[15] National Pulmonary Vascular Diseases Unit,undefined
[16] Papworth Hospital,undefined
[17] University of Barcelona,undefined
[18] and Biomedical Research Networking Center on Respiratory Diseases,undefined
[19] Clinic for Respiratory Medicine,undefined
[20] Hannover Medical School,undefined
[21] Université Libre de Bruxelles,undefined
[22] Medizinische Universität Wien,undefined
[23] Global Development,undefined
[24] Global Medical Affairs,undefined
[25] Bayer AG,undefined
[26] Global Clinical Development,undefined
[27] University of Pavia School of Medicine,undefined
来源
关键词
Riociguat; Chronic thromboembolic pulmonary hypertension; Early access study;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Riociguat as bridging therapy to pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a retrospective cohort study
    Zhang, Zhaohua
    Liu, Jingwen
    Zhen, Yanan
    Liu, Xiaopeng
    Xu, Mingyuan
    Ma, Junyu
    Wen, Jianyan
    Liu, Peng
    JOURNAL OF THORACIC DISEASE, 2024, 16 (06) : 3540 - 3552
  • [22] Riociguat As A Bridge Therapy For Balloon Pulmonary Angioplasty In Patients With Chronic Thromboembolic Pulmonary Hypertension
    Ueda, J.
    Ogo, T.
    Fukui, S.
    Tsuji, A.
    Morita, Y.
    Fukuda, T.
    Yasuda, S.
    Ogawa, H.
    Nakanishi, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [23] Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Benza, Raymond L.
    Langleben, David
    Hemnes, Anna R.
    Noordegraaf, Anton Vonk
    Rosenkranz, Stephan
    Thenappan, Thenappan
    Hassoun, Paul M.
    Preston, Ioana R.
    Ghio, Stefano
    Badagliacca, Roberto
    Vizza, Carmine D.
    Lang, Irene M.
    Meier, Christian
    Gruenig, Ekkehard
    EUROPEAN RESPIRATORY REVIEW, 2022, 31 (166):
  • [24] Effects of Riociguat on Right Ventricular Remodelling in Chronic Thromboembolic Pulmonary Hypertension Patients: A Prospective Study
    Ahmadi, Ali
    Thornhill, Rebecca E.
    Pena, Elena
    Renaud, Jennifer M.
    Promislow, Steven
    Chandy, George
    Davies, Ross A.
    Stewart, Duncan J.
    Contreras-Dominguez, Vladimir
    Dunne, Rosemary
    Doyle-Cox, Carolyn
    Beanlands, Rob S.
    dekemp, Robert A.
    Mielniczuk, Lisa M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (09) : 1137 - 1144
  • [25] REVEAL Risk Score in Patients with Chronic Thromboembolic Pulmonary Hypertension Receiving Riociguat
    Benza, R. L.
    Farber, H. W.
    Frost, A.
    Grunig, E.
    Hoeper, M.
    Busse, D.
    Meier, C.
    Nikkho, S.
    Ghofrani, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S20 - S20
  • [26] Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Benza, Raymond L.
    Ghofrani, Hossein-Ardeschir
    Grunig, Ekkehard
    Hoeper, M. Marius
    Jansa, Pavel
    Jing, Zhi-Cheng
    Kim, Nick H.
    Langleben, David
    Simonneau, Gerald
    Wang, Chen
    Busse, Dennis
    Meier, Christian
    Ghio, Stefano
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (10): : 1172 - 1180
  • [27] Economic Evaluation of Riociguat in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension
    Avxentyeva, M. V.
    Chernyavskiy, A. M.
    Pyadushkina, E. A.
    KARDIOLOGIYA, 2015, 55 (03) : 33 - 40
  • [28] REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat
    Benza, Raymond L.
    Farber, Harrison W.
    Frost, Adaani
    Gruenig, Ekkehard
    Hoeper, Marius M.
    Busse, Dennis
    Meier, Christian
    Nikkho, Sylvia
    Ghofrani, Hossein-Ardeschir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (07): : 836 - 843
  • [29] EFFECT OF RIOCIGUAT ON RIGHT VENTRICULAR FUNCTION IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Benza, Raymond
    Ghofrani, Hossein
    Hoeper, Marius
    Jansa, Pavel
    Kim, Nick
    Simonneau, Gerald
    Meier, Christian
    Busse, Dennis
    CHEST, 2018, 154 (04) : 1065A - 1066A
  • [30] Riociguat Dose Titration in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) or Pulmonary Arterial Hypertension (PAH)
    Ghofrani, H. A.
    Hoeper, M. M.
    Hoeffken, G.
    Halank, M.
    Weimann, G.
    Grimminger, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179